Calendar of Events & Lectures

Today
This Week

Monday, March 6, 2017

Defining, Optimizing, and Changing the Specificities of CRISPR-Cas Nucleases

| 105 ZRC, MSKCC, 417 EAST 68TH STREET
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
Keith Joung, M.D., Ph.D., professor, department of pathology, Harvard Medical School

T Cell Exhaustion: Mechanisms and Role in Precision Immune Oncology

| AUDITORIUM, ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
John Wherry, Ph.D., director, Penn Institute for Immunology, Richard and Barbara Schiffrin President's Distinguished Professor, department of microbiology, Perelman School of Medicine at the University of Pennsylvania

Sustainable Seas: The Vision, The Reality

| CASPARY AUDITORIUM
Special Events, Lewis Thomas Prize
Sylvia Earle, Ph.D., National Geographic Society Explorer-in-Residence and founder of Mission Blue

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)

Spying on the Immune System

| CASPARY AUDITORIUM
The Philip Levine Memorial Lecture

News

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

This new insight into T cell receptors may improve cancer immunotherapies

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Room Reservation Calendar